Pea Protein Market Is Expected To Rise At A CAGR Of 17.4% From 2017 To 2025

Global Pea Protein Market is expected to reach USD 313.5 million by 2025, according to a new report by Grand View Research, Inc. Increasing consumption of gluten-free products for treatment of celiac disease is expected to boost the pea proteins demand during the forecast period.

Rising concerns over non-celiac gluten sensitivity is expected to result in rising consumption of gluten-free foods and is hence anticipated to positively impact the industry growth. Furthermore, the popularity of maintaining a gluten-free diet (GFD) owing to reduced carbohydrate intake and stimulation of weight loss is anticipated to propel the use of pea proteins over the forecast period.

Increasing importance of maintaining a GFD in treating innate immune response, joint pain, and numbness is foreseen to fuel the product demand in the future. Furthermore, this diet is gaining popularity as an effective treatment for curing symptoms of autism in children. This in turn is expected to drive the pea protein demand over the forecast period.

Significant prevalence of lactose intolerance among infants and children in developing regions such as Central & South America, Asia Pacific, and Middle East & Africa is projected to be another significant driver of the industry growth. Pea protein is one of the highly preferred non-dairy substitutes, as it is characterized by good amino acid profile and is easily digestible. These attributes make the product favorable for use in various food & beverage products such as protein fortified health drinks and sports nutritional foods.

Full Research Report on Global Pea Protein Market Analysis: http://www.grandviewresearch.com/industry-analysis/pea-protein-market

Further key findings from the report suggest:

• In terms of volume, bakery goods application is expected to rise at a CAGR of 13.6% from 2017 to 2025, owing to the utilization of pea protein as a fibrous and gluten-free product
• Pea concentrates accounted for a revenue share of 27.2% in 2016. These products comprise 70-80% of protein content and are favorably used in energy drinks and fruit mixes applications
• The growth of the food & beverage industry in Brazil, India, China, and Mexico as a consequence of increasing domestic consumption coupled with the adoption of modern farming technology is expected to drive the industry growth in the near future
• Companies are focusing on enhancement of their business growth through significantly investing in research & development, new product launches, and forward integration. Farbest and Roquette America have forward integrated business operations as they are engaged in the production as well as supply operations.
• In October 2014, Comax Flavors launched a new pea protein masking range of food additives owing to minimize or reduce the unpleasant flavor in the processed goods
• In April 2014, Carmit Candy Industries launched a wafer snack bar fortified with a dark chocolate coating and containing pea protein aimed at eliminating the pea protein flavor

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/nutraceuticals-functional-foods-and-dietary-supplements

Grand View Research has segmented the Global Pea Protein Market on the basis of product, application, and region:

Pea Protein Product Outlook (Volume, Tons; Revenue, USD Thousand; 2014 - 2025)

• Isolates
• Concentrates
• Textured

Pea Protein Form Outlook (Volume, Tons; Revenue, USD Thousand; 2014 - 2025)

• Dry
• Liquid

Pea Protein Application Outlook (Volume, Tons; Revenue, USD Thousand; 2014 - 2025)

• Meat extenders & analogues
• Bakery Goods
• Dietary Supplements
• Beverage
• Others

Pea Protein Regional Outlook (Volume, Kilo Tons; Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Mexico
• Europe
• UK
• Germany
• France
• Asia Pacific
• China
• Japan
• Australia
• Central & South America
• Brazil
• Middle East & Africa

Access Press Release of this research report by Grand View Research: http://www.grandviewresearch.com/press-release/global-pea-proteins-market           

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Flow Chemistry Market Is Likely To Witness Considerable Growth Owing To Rising Penetration Of The Product In Pharmaceuticals 2014-2025

Global Flow Chemistry Market is expected to reach a market size of USD 2.39 billion by 2025, according to a new report by Grand View Research, Inc. Increasing focus towards cost effectiveness, safety, and environmental regulations are expected to have a positive impact on the demand over the forecast period.

The flow chemistry involves a continuous flow of chemical processes in order to develop intermediate chemicals that are complex to achieve through the batch manufacturing process. High control over factors such as reaction time, temperature, flow, pumped volumes, and pressure allows increased safety levels in the process.

Full Research Report on Global Flow Chemistry Market Analysis:
http://www.grandviewresearch.com/industry-analysis/flow-chemistry-market

Further key findings from the report suggest:

• Petrochemicals accounted for a significant market share and is expected to witness a CAGR of over 9%, in terms of revenue on account of highly favorable conditions for the ethylene and polyethylene manufacturers in North America
• Pharmaceutical industry is expected to witness the fastest growth over the forecast period on account of high flexibility in choice of the solvents as well as temperature & pressure conditions, thereby resulting in high purity product
• Continuous stirred tank reactor segment is expected to grow at a CAGR of over 8% from 2015 to 2025 on account of its high penetration in industrial processing
• Asia Pacific is expected to witness a CAGR of over 11% from 2016 to 2025 on account of rapidly growing investment in pharmaceutical and chemical manufacturing in China and India
• The flow chemistry industry in Central & South America is majorly driven by rapid urbanization and rising demand for generic drugs
• In February 2016, Chemtrix appointed Central Scientific Commerce as its distributor in Japan in order to facilitate direct reactor sales and customer support to the R&D and production communities in the economy
• In November 2015, Biotage AB opened a demonstration & application lab in Sweden which facilitated further research across all the product lines of the company

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/petrochemicals-and-downstream-derivatives

Grand View Research has segmented the Global Flow Chemistry Market on the basis of application, reactor, and region:

Application Outlook (Revenue, USD Million; 2014 - 2025)

• Pharmaceuticals
• Chemicals
• Academia & Research
• Petrochemicals
• Others

Reactor Outlook (Revenue, USD Million; 2014 - 2025)

• CSTR
• Plug Flow Reactor
• Microreactor
• Microwave System
• Others

Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Europe
• Germany
• UK
• Asia Pacific
• China
• India
• Japan
• Central & South America
• Brazil
• Middle East & Africa

Access Blog On this research report by Grand View Research: http://www.grandviewresearch.com/blog/flow-chemistry-market-size-share             

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Smart Cards Market Is Estimated To Grow At A CAGR of 7.9% During Forecast Period 2014-2025

Global Smart Cards Market is predicted to reach USD 15.4 billion by 2025, according to a new study by Grand View Research, Inc. The increasing demand for the product, across various applications, such as payment transactions, cell phones, ID verification & access controls, is presumed to favor the market growth over the forecast period. Smart cards are used in several applications including the retail, healthcare, government, and hospitality sectors, promoting the market demand over the forecast period by providing effective data storage, efficient payment transactions, and faster processing time.

The increasing use of smart cards in the telecommunication and BFSI segments is expected to drive the market over the next nine years. Their implementation in retail applications enables secure transactions and provides new opportunities to the market.

Smart cards are extensively used to enable secure payment transactions and to promote cashless payments, thereby, enabling cost savings for payment merchants and offering convenience to the consumers. The use of mobile phones and IoT devices has further promoted the use of SIM & data chips thereby driving the demand for the product. These devices are increasingly used in retail applications to enable faster transactions and reduce the checkout time. These advantages are enabling growth of the industry at a significant rate, over the next nine years.

Full Research Report on Global Smart Cards Market Analsysis:
http://www.grandviewresearch.com/industry-analysis/smart-card-industry

Further key findings from the study suggest:

• The telecommunication application segment dominated the overall market in 2015 and accounted for over 46% of the market in the same year
• The contact cards segment was a key segment in 2015 and accounted for over 65% of the overall industry revenue
• Contact cards provide ease of transactions, owing to their low costs and low handling-charges. Contactless cards are also expected to grow, significantly, due to the elimination of physical card insertion and better security.
• The microcontroller-based segment accounted for over 70% of the overall smart cards market in 2015
• The Asia Pacific region is expected to significantly contribute to the industry growth and accounted for over 45% of the global industry revenue in 2015
• The key industry participants include American Express Company, Atos SE, CPI Card Group, Gemalto NV, Giesecke & Devrient (G&D) GmbH, Infineon Technologies AG, Inside Secure SA, NXP Semiconductors NV, and Texas Instruments, Inc.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/emerging-and-next-generation-technologies

Grand View Research has segmented the Global Smart Cards Market based on type, component, application and region:

Smart Cards Type Outlook (Revenue, USD Million; 2014 - 2025)

• Contact cards
• Contactless cards
• Multi-component cards

Smart Cards Component Outlook (Revenue, USD Million; 2014 - 2025)

• Memory-based
• Microcontroller-based

Smart Cards Application Outlook (Revenue, USD Million; 2014 - 2025)

• BFSI
• Government
• Telecommunications
• Retail
• Healthcare
• Hospitality
• Others

Smart Cards Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• Europe
• Russia
• Asia Pacific
• Rest of the world

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-smart-card-market        

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

Electroencephalography Devices Market Is Anticipated To Grow At A CAGR Of 7.6% over the forecast period 2014-2025

Global EEG Devices/Systems Market is expected to reach a value of USD 1.40billion by 2025, according to a new report by Grand View Research, Inc. Increasing prevalence of neurological disorders such as epilepsy, sleeping disorders, brain tumor, Parkinson’s disease, and stroke is a major factor anticipated to drive market growth during the forecast period. According to WHO, over 50 million people are affected by epilepsy; and more than 35.6 million people worldwide are suffering from Alzheimer’s disease and dementia. Thus, the increasing prevalence of neurological disorders leads to rising demand for EEG systems and equipment. In addition, growing awareness about neurological diseases in developed and developing regions is expected to boost the market.

Increasing funding for neuroscience R&D by governments is another main factor contributing to the market growth. For instance, in June 2014, the U.S. Department of Defense granted USD 400,000 to University of Texas at San Antonio for the purchase of two EEG systems intended for advance research on brain-machine interaction. Also, technological advancement in these systems propels its adoption for detection of abnormalities associated with electrical activity of the brain. Thus, government initiatives and technological advancement are expected to drive the growth of the sector in the near future.

Full Research Report on Global Electroencephalography (EEG) Devices Market Analysis: http://www.grandviewresearch.com/industry-analysis/electroencephalography-eeg-systems-devices-market

Further Key Findings From the Study Suggest:

• The 32-channel EEG segment was the highest revenue generating segment of the market in 2015. The technological advancement in 32-channel EEG products propels the segment growth
• In 2015, the standalone devices segment was the highest revenue grossing segment of the market due to its high application in hospitals and diagnostics centers
• The hospitals segment held the largest revenue share in the market in 2015, owing to the increasing number of patients suffering from neurological disorders. The rising geriatric population is another major factor responsible for the growth of the hospitals segment during study period
• North America accounted for the largest revenue share of the EEG devices market in the year 2015. The availability of insurance coverage for brain monitoring and well-developed healthcare infrastructure is anticipated to drive demand for EEG products in the region during the forecast period
• Some of the key companies are Natus Medical, Inc.; NeuroWave Systems, Inc.; Electrical Geodesics, Inc.; Medtronic; Compumedics Ltd.; Cadwell Laboratories, Inc.; Noraxon U.S.A. Inc.; and Nihon Kohden America, Inc.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the Electroencephalography (EEG) Devices Market on the basis of product, type, end use, and region:

EEG Devices Product Outlook (Revenue, USD Million; 2014 - 2025)

• 8-channel EEG
• 21-channel EEG
• 25-channel EEG
• 32-channel EEG
• 40-channel EEG
• Multichannel EEG

EEG Devices Type Outlook (Revenue, USD Million; 2014 - 2025)

• Standalone devices
• Portable devices

EEG Devices End-Use Outlook (Revenue, USD Million; 2014 - 2025)

• Hospitals
• Diagnostic Centers
• Others

EEG Devices Regional Outlook (Revenue, USD Million; 2014 - 2025)

• North America
• U.S.
• Canada
• Europe
• Germany
• UK
• Asia Pacific
• China
• Japan
• India
• Latin America
• Brazil
• Mexico
• MEA
• South Africa

View Blog on This Research Report By Grand View Research: http://www.grandviewresearch.com/blog/electroencephalogram-eeg-devices-market-size-share     

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

Egg Phosphatidylcholine Market Is Poised To Reach USD 12.2 Million By 2020

Global Egg Phosphatidylcholine Market is poised to reach USD 12.2 million by 2020.Key factors attributing to its rapid growth include the presence of high chlorine essential nutrient content which helps patients to recover from memory loss. Growing occurrence of neurological diseases including amnesia and Alzheimer’s among aged population is expected to increase the demand for egg phosphatidylcholine.

Full Research Report on Global Egg Phosphatidylcholine Market Analysis:
http://www.grandviewresearch.com/industry-analysis/egg-phosphatidylcholine-market

Demand for egg phosphatidylcholine is expected to grow over the forecast period owing to increasing awareness among consumers regarding consumption of food high with nutritional value. Increasing awareness among youth to use quality cosmetic products is expected to further propel growth.

In cosmetics, the compound is used as a solubilizer, moisturizer and emulsifier for different ointments. It helps in preventing cellular damage to the skin structure and provides elasticity and smoothness. The segment is expected to grow at a CAGR of 5.0% over the forecast period to reach a value exceeding USD 2.1 million by 2020.

Dietary supplements were valued at USD 5.7 million in 2013 and is expected to grow at a CAGR of 5.6% during the forecast period. Rising consumer awareness regarding general well-being by consumption of essential nutrientsis expected to fuel growth.

Egg phosphatidylcholine demand for pharmaceutical exceeded USD 1.2 million in 2013. They help in enhancing solubility of active ingredients in pharmaceutical formulations. Increasing government spending on the development of the healthcare sector across the globe is expected to bolster growth.

Europe was the leading market accounting for 34.0% of the global industry in 2013 owing to high consumer awareness regarding the benefits of the ingredient. Rising demand for cosmetics in countries including Germany, France, Italy and UK is expected to increase demand over the forecast period.

Demand for the product in North America is being driven due to the presence of numerous dietetic supplement manufacturers in the region. The market is estimated to reach a value of USD 3.70 million by 2020.

Asia Pacific is expected to grow at a CAGR of 10.2% over the forecast period. Increasing demand for egg phosphatidylcholine in various end-use applications including cosmetics, pharmaceuticals and dietary supplements coupled with the growth of these end-use industries is expected to drive growth.

Prominent players in the industry include NOF America Corporation, Jena Bioscience GmbH, Harmony Whole Foods Market, Natural Factors, Kewpie Corporation, Nutrasal Inc., Avanti Polar Lipids Inc. and Vitamin Research Products. The industry has a high degree of consolidation owing to limited number of manufacturers. In addition, volatility in raw material and product pricing will deter the entry of new players.

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/nutraceuticals-functional-foods-and-dietary-supplements

Grand View Research has segmented the Global Egg Phosphatidylcholine Market on the basis of application and region:

Egg Phosphatidylcholine Applications Outlook (Revenue, USD Million, 2012 - 2020)

• Cosmetics
• Pharmaceuticals
• Dietetic Supplements

Egg Phosphatidylcholine Regional Outlook (Revenue, USD Million, 2012 - 2020)

• North America
• Europe
• Asia Pacific
• RoW

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-egg-phosphatidylcholine-market    

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

eClinical Solutions Market Is Segmented On the Basis Of End-User Application And Region 2013-2024

eClinical Solutions Market is expected to reach USD 10.5 billion by 2024, according to a new report published by Grand View Research Inc. The eClinical solutions market is anticipated to witness a lucrative growth during the period 2016 to 2024. The factors attributing towards the growth of the market are increase in the research and development activities by numerous biopharma and pharma companies, increasing application of software solutions in clinical trials, upsurge in the government funding to promote clinical research programs, rise in the number of Contract Research Organizations (CROs) and life sciences organizations, and increasing customer base. 

Additionally, factors such as increasing outsourcing of clinical trials to CROs, escalating clinical research programs in Asian countries, as well as, the development of cost-effective modules are expected to be opportunistic for the industry growth. However, the shortage of skilled labor force, high implementation costs of the eClinical solutions and the lack of awareness of clinical data sciences software in the research community are likely to hinder the growth of the market in the near future. 

The eClinical solutions market is segmented on the basis of product, delivery mode, clinical trial phase, end-user, and region. Based on the product, the industry is categorized into clinical analytics platforms, electronic Clinical Outcome Assessment (eCOA), Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS), clinical data integration platforms, safety solutions, Clinical Trial Management Systems (CTMS), Randomization and Trial Supply Management (RTSM), and electronic Trial Master File (eTMF). 

The other segments of the market include delivery mode (web-hosted, licensed enterprise, and cloud-based), clinical trial phases (phase I, phase II, phase III, and phase IV), and end-user application (consulting service companies, medical device manufacturers, hospitals, contract research organizations, pharmaceutical, and biopharmaceutical companies). On the basis of regions, the market is categorized into North America, Europe, Asia-Pacific, Latin America, and the Middle East and Africa).

Full Research Report on Global eClinical Solutions Market Analysis:
http://www.grandviewresearch.com/industry-analysis/eclinical-solutions-market

Further key findings from the study suggest:

• In 2016, North America is estimated to lead the market with the largest share in the eClinical solutions industry. The rising number of ongoing clinical trials, high demand for technologically advanced products, and increasing financial support from the government is anticipated to boost the industry growth.
• The eCOA segment is anticipated to witness the highest growth rate during the forecast period, whereas the EDC and CDMS segment is estimated to lead the market in the year 2016. Factors attributing to the growth of the industry are the increasing application of mobile and digital technologies, as well as, an upsurge in the demand for eDiaries in clinical trials for the collection of patient’s self-reports by pharmaceutical companies.
• The eClinical solutions industry comprises several local as well as global players. Some of the major players in this industry include Oracle Corporation, Medidata Solutions Inc., Parexel International, Inc., and Datatrak, among others. 

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/healthcare-it

Grand View Research has segmented the Global eClinical Solutions Market on the basis of end-user application and region:

eClinical Solutions Product Outlook (Revenue, USD Million, 2013 - 2024)

• Electronic Data Capture (EDC) and Clinical Data Management Systems (CDMS) 
• Clinical Trial Management Systems (CTMS)
• Clinical Analytics Platforms
• Randomization and Trial Supply Management (RTSM) 
• Clinical Data Integration Platforms
• Electronic Clinical Outcome Assessment (eCOA)
• Safety Solutions
• Electronic Trial Master File (eTMF) 

eClinical Solutions Delivery Mode Outlook (Revenue, USD Million, 2013 - 2024)

• Web-hosted (On-demand)
• Licensed Enterprise (On-premise)
• Cloud-based 

eClinical Solutions Delivery Mode Outlook (Revenue, USD Million, 2013 - 2024)

• Consulting Service Companies
• Medical Device Manufactures
• Hospitals
• CROs
• Pharmaceutical Biopharmaceutical Companies 

eClinical Solutions Clinical Trial Outlook (Revenue, USD Million, 2013 - 2024)

• Phase I
• Phase II
• Phase III
• Phase IV 

eClinical Solutions Regional Outlook (Revenue, USD Million, 2013 - 2024)

• North America
• Europe
• Asia Pacific
• Latin America
• MEA

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-eclinical-solutions-market   

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com

Defoamers Market Size Is Anticipated To Reach $4.4 Billion By 2025

Global Defoamers Market is expected to reach USD 4.4 Billion by 2025, according to a new report by Grand View Research, Inc. Rising investment on water treatment operation across the globe has driven the global defoamers market. Furthermore, growth in pulp & paper production in developing regions of the world has fueled the demand.

Water-based defoamers segment has experienced robust growth over the past few years, owing to environmental benefits associated with it. Shift in consumer preferences towards environmentally sustainable products is expected to result in increased share of water-based defoamers over the next few years.

Silicone-based defoamers dominated the global market, accounting for more than 38% share of the total revenue. Wide usage of silicone-based defoamers in major end-user industries including pulp & paper and water treatment attributed for the largest share. The share of oil-based defoamers is estimated to decline, owing to stringent environmental regulations.

Pulp & paper was the largest application segment of the global defoamers market in 2016. Growth of pulp & paper industry in developing regions such as Asia Pacific, Eastern Europe, and Latin America has fueled the demand for defoamers in the recent past. Demand from agrochemicals and coatings applications is expected to increase at a fast pace.

Full Research Report on Global Defoamers Market Analysis:
http://www.grandviewresearch.com/industry-analysis/defoamers-market

Further key findings from the report suggest:

• The global defoamers market was valued at USD 2,938.2 million in 2016 and is expected to grow at a CAGR of 4.7% from 2017 to 2025
• Silicone-based defoamers accounted to be the largest product segment in 2016 and is estimated to account for more than 38% share by 2025
• Water-based defoamers segment is likely to expand at the fastest growth rate of 5.1% from 2017 to 2025
• Pulp & paper is estimated to be the highest revenue generating segment of the global defoamers market in 2025, accounting for more than 27% of the revenue share
• Defoamers for coatings application is expected to reach USD 1,112.9 million by 2025, owing to rising demand in waterborne coatings
• Asia Pacific dominated the global defoamers market and the region is anticipated to maintain its leading position over the forecast period, accounting for around 44% share of the revenue
• Positive outlook in pulp & paper production coupled with prospective growth in coatings industry in China, India, and South East Asian countries is expected to drive the demand in Asia Pacific region
• North America was the second-leading player in the regional market, accounting for more than 21% share in 2016
• Producers including BASF SE, Applied Material Solutions, Wacker Chemie AG, Kemira Oyj, Shin Etsu Chemical Co., Ltd, Dow Corning Corp, Air Products and Chemicals Inc., and Evonik Industries AG were the leading players in global defoamers market
• Fragmented nature of the market coupled with integrated operation led to intense competition

View more reports of this category by Grand View Research at: http://www.grandviewresearch.com/industry/specialty-and-fine-chemicals

Grand View Research has segmented the Global Defoamers Market on the basis of product, application, and region:

Defoamers Product Outlook (Revenue, USD Million, 2014 - 2025)

• Water-based
• Oil based defoamers
• Silicone based defoamers
• Others

Defoamers Application Outlook (Revenue, USD Million, 2014 - 2025)

• Pulp & paper
• Coatings
• Agrochemicals
• Water treatment
• Food & Beverage
• Others

Defoamers Regional Outlook (Revenue, USD Million, 2014 - 2025)

• North America
• U.S.
• Canada
• Mexico
• Europe
• Germany
• UK
• Asia Pacific
• China
• India
• Central & South America
• Brazil
• Middle East & Africa

View Press Release Of This Research Report By Grand View Research: http://www.grandviewresearch.com/press-release/global-defoamers-market  

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more Information visit us: www.grandviewresearch.com